Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors

Kemal KÖSEMEHMETOĞLU; Ece ÖZOĞUL; Berrin BABAOĞLU; Gaye GÜLER TEZEL<sup>1; 2</sup>; Gökhan GEDİKOĞLU

doi:10.5146/tjpath.2017.01395

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE)

Table of Contents

2017, Volume 33, Number 3, Page(s) 192-197

[ Abstract (English) ] [ Full Text (English) ] [ PDF ]

DOI: 10.5146/tjpath.2017.01395

Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors

Kemal KÖSEMEHMETOĞLU¹, Ece ÖZOĞUL¹, Berrin BABAOĞLU¹, Gaye GÜLER TEZEL^1,2, Gökhan GEDİKOĞLU¹

¹Department of Pathology, Research and Application Center, Hacettepe University, Faculty of Medicine, ANKARA, TURKEY
²Department of Molecular Pathology, Research and Application Center, Hacettepe University, Faculty of Medicine, ANKARA, TURKEY

[ Abstract (English) ] [ PDF ]